Correlation Between Surrozen and Aptinyx
Can any of the company-specific risk be diversified away by investing in both Surrozen and Aptinyx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Surrozen and Aptinyx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Surrozen and Aptinyx, you can compare the effects of market volatilities on Surrozen and Aptinyx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Surrozen with a short position of Aptinyx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Surrozen and Aptinyx.
Diversification Opportunities for Surrozen and Aptinyx
Very good diversification
The 3 months correlation between Surrozen and Aptinyx is -0.29. Overlapping area represents the amount of risk that can be diversified away by holding Surrozen and Aptinyx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aptinyx and Surrozen is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Surrozen are associated (or correlated) with Aptinyx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aptinyx has no effect on the direction of Surrozen i.e., Surrozen and Aptinyx go up and down completely randomly.
Pair Corralation between Surrozen and Aptinyx
If you would invest 675.00 in Surrozen on August 24, 2024 and sell it today you would earn a total of 255.00 from holding Surrozen or generate 37.78% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Insignificant |
Accuracy | 0.4% |
Values | Daily Returns |
Surrozen vs. Aptinyx
Performance |
Timeline |
Surrozen |
Aptinyx |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Surrozen and Aptinyx Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Surrozen and Aptinyx
The main advantage of trading using opposite Surrozen and Aptinyx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Surrozen position performs unexpectedly, Aptinyx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aptinyx will offset losses from the drop in Aptinyx's long position.Surrozen vs. Lyra Therapeutics | Surrozen vs. Hookipa Pharma | Surrozen vs. Cingulate Warrants | Surrozen vs. SAB Biotherapeutics |
Aptinyx vs. Aileron Therapeutics | Aptinyx vs. ABVC Biopharma | Aptinyx vs. CytomX Therapeutics | Aptinyx vs. Assembly Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the CEOs Directory module to screen CEOs from public companies around the world.
Other Complementary Tools
Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
Fundamental Analysis View fundamental data based on most recent published financial statements |